Skip to main content
Glama

Compare Entities

compare_entities
Read-onlyIdempotent

"Compare X and Y" / "X vs Y" / "X versus Y" / "which is bigger / better / larger / more profitable" / "rank these companies" / "head to head" — side-by-side comparison of 2–5 companies or drugs in ONE parallel call. ALWAYS PREFER over sequential single-pack lookups when comparing entities. type="company" pulls LATEST 10-K revenue + net income + cash + long-term debt from SEC EDGAR/XBRL (off-calendar fiscal years handled correctly — AAPL Sep, NVDA Jan, etc.). type="drug" pulls FAERS adverse-event counts, FDA approval counts, active trial counts. Results sorted by primary metric so "largest" / "most" / "biggest" reads off the top of the response. Returns paired data + pipeworx:// citation URIs per entity. Replaces 8–15 sequential lookups.

Input Schema

TableJSON Schema
NameRequiredDescriptionDefault
typeYesEntity type: "company" or "drug".
valuesYesFor company: 2–5 tickers/CIKs (e.g., ["AAPL","MSFT"]). For drug: 2–5 names (e.g., ["ozempic","mounjaro"]).

Schema Changelog

Changes observed during successful MCP inspections. Dates show when Glama detected each change.

  1. First observed

TDQS

A5/5.0
Behavior5/5

Does the description disclose side effects, auth requirements, rate limits, or destructive behavior?

Beyond annotations (readOnly, idempotent, etc.), the description discloses data sources (SEC EDGAR/XBRL, FAERS), specific metrics pulled (revenue, net income, adverse events, trial counts), sorting behavior by primary metric, and output structure (paired data + citation URIs). This far exceeds annotation coverage.

Agents need to know what a tool does to the world before calling it. Descriptions should go beyond structured annotations to explain consequences.

Conciseness5/5

Is the description appropriately sized, front-loaded, and free of redundancy?

The description is dense but every sentence carries high-value information: trigger phrases, preference over alternatives, data specifics, sorting, and output format. It is front-loaded and avoids filler while being remarkably informative.

Shorter descriptions cost fewer tokens and are easier for agents to parse. Every sentence should earn its place.

Completeness5/5

Given the tool's complexity, does the description cover enough for an agent to succeed on first attempt?

Despite no output schema, the description specifies return contents (paired data, citation URIs), sorting, and entity count limits. It fully covers what a user needs to know for a comparison tool with only 2 parameters, and also notes handling of off-calendar fiscal years.

Complex tools with many parameters or behaviors need more documentation. Simple tools need less. This dimension scales expectations accordingly.

Parameters5/5

Does the description clarify parameter syntax, constraints, interactions, or defaults beyond what the schema provides?

Schema coverage is 100%, but the description enriches meaning by explaining what each type ('company' vs 'drug') retrieves and providing concrete examples (AAPL/MSFT, ozempic/mounjaro). It also clarifies the values array constraints via examples.

Input schemas describe structure but not intent. Descriptions should explain non-obvious parameter relationships and valid value ranges.

Purpose5/5

Does the description clearly state what the tool does and how it differs from similar tools?

The description explicitly states 'side-by-side comparison of 2–5 companies or drugs in ONE parallel call' and lists trigger phrases like 'X vs Y' and 'rank these companies'. It clearly distinguishes from sibling tool entity_profile, which likely handles single-entity lookups.

Agents choose between tools based on descriptions. A clear purpose with a specific verb and resource helps agents select the right tool.

Usage Guidelines5/5

Does the description explain when to use this tool, when not to, or what alternatives exist?

It explicitly instructs 'ALWAYS PREFER over sequential single-pack lookups when comparing entities', establishing clear when-to-use. It also gives per-type guidance (company vs drug) and implies alternatives for single lookups via entity_profile.

Agents often have multiple tools that could apply. Explicit usage guidance like "use X instead of Y when Z" prevents misuse.

Try in Browser

Glama MCP Gateway

Add one secure layer between your agents and this server.

TDQS

A3.6/5.0
Disambiguation3/5

Many tools have distinct purposes, but there is overlap among data query tools (ask_pipeworx, ask_pipeworx_grounded, deep_research) and numerous Polymarket bet tools, which could cause confusion. Tool descriptions are detailed and help differentiate, but the diversity of domains requires careful reading.

Naming Consistency2/5

Tool names follow inconsistent patterns: some are snake_case verb_noun (query_layer, search_datasets), others are noun_verb (bet_research) or compound names (pipeworx_feedback, polymarket_arbitrage). There is no uniform convention, making it harder for agents to predict tool names.

Tool Count2/5

With 33 tools, the server feels overloaded for its apparent ArcGIS focus. Most tools are unrelated to ArcGIS (Polymarket, Pipeworx data, memory, subscriptions), suggesting a lack of scope. The count is high without a clear unifying purpose.

Completeness2/5

The tool surface is incomplete for any single domain. ArcGIS coverage is minimal (only query and schema), Pipeworx data tools are abundant but without a clear workflow, and Polymarket betting lacks order placement. The server tries to cover too many areas resulting in shallow coverage.